← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2006Last known activity
Mar 31, 2019
Acquired by ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. on Dec 21, 2020
Timeline
2000s
- Jun 1, 2003
NantCell, Inc.— Founded
2010s
- Jun 27, 2017
Altor Bioscience— Acquired
2020s
- Dec 21, 2020
ImmunityBio, Inc.— Acquired By
- Dec 21, 2020
ImmunityBio, Inc.— Now
Drugs by trial phase (43 distinct, 44 trials)
Phase 3 (1 own, 3 via acquisition)
Phase 2 (16 own, 14 via acquisition)
Phase 1 (2 own, 7 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Merkel Cell
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Colonic Neoplasms
- Colorectal Neoplasms
- Desmoplastic Small Round Cell Tumor
- Endocrine Gland Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, Non-Hodgkin
- Melanoma
- Neoplasm Metastasis
- Neoplasms
- Neuroectodermal Tumors
- Neuroectodermal Tumors, Primitive
- Neuroectodermal Tumors, Primitive, Peripheral
- Pancreatic Neoplasms
- Sarcoma
- Sarcoma, Ewing
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Thyroid Neoplasms
- Triple Negative Breast Neoplasms
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (24)
- NCT03853317CollaboratorPhase 2Mar 31, 2019
- NCT03520686CollaboratorPhase 2May 18, 2018
- NCT03169777Lead sponsorPhase 1/Phase 2Aug 1, 2017
- NCT03169738Lead sponsorPhase 1/Phase 2Aug 1, 2017
- NCT03167164Lead sponsorPhase 1/Phase 2Aug 1, 2017
- NCT03169764Lead sponsorPhase 1/Phase 2Aug 1, 2017
- NCT03167177Lead sponsorPhase 1/Phase 2Aug 1, 2017
- NCT03169790Lead sponsorPhase 1/Phase 2Aug 1, 2017
- NCT03175666Lead sponsorPhase 1/Phase 2Aug 1, 2017
- NCT03127098Lead sponsorPhase 1/Phase 2May 1, 2017
- NCT03136406Lead sponsorPhase 1/Phase 2May 1, 2017
- NCT03029481CollaboratorN/AJan 20, 2017
- NCT01708161CollaboratorPhase 1/Phase 2Nov 27, 2012
- NCT01231347Lead sponsorPhase 3Apr 1, 2011
- NCT01147965Lead sponsorPhase 1/Phase 2Jun 1, 2010
Details
- Founded
- Seattle, WA, US Jun 1, 2003
- Last known activity
- Mar 31, 2019
Notes
--- Pre-folding founded info: 2014-06-01 Culver City CA United States https://www.crunchbase.com/organization/nantcell-llc ---